Catalyst Pharmaceutical
CPRX
CPRX
80 hedge funds and large institutions have $89.7M invested in Catalyst Pharmaceutical in 2017 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 21 increasing their positions, 17 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
4% less capital invested
Capital invested by funds: $93.7M → $89.7M (-$4.01M)
36% less call options, than puts
Call options by funds: $83K | Put options by funds: $130K
Holders
80
Holding in Top 10
–
Calls
$83K
Puts
$130K
Top Buyers
| 1 | +$2.09M | |
| 2 | +$1.21M | |
| 3 | +$931K | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$889K |
| 5 |
Morgan Stanley
New York
|
+$671K |
Top Sellers
| 1 | -$1.15M | |
| 2 | -$782K | |
| 3 | -$782K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$519K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$190K |